The regulator has suggested that it treat every edit of an animal’s genome like a new drug, but some scientists think it could slow progress.
Filling a gap that pharma fails to fund, a new initiative will develop vaccines to prevent outbreaks of emerging viruses.
More than half of pediatric cancer patients have genetic faults that could affect their diagnosis or be targeted by drugs.
A startup uses algorithms that understand the anatomy of cells to discover new uses for existing drugs.
Her death is a reminder that antibiotic-resistant bacteria are getting worse, even as they garner little attention.
Experts warn that a potential IVF breakthrough could have unintended social consequences.
The technique could be faster and more versatile than developing genetically modified crops from scratch.
Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach.
Researchers have tested a modified malaria parasite in humans that has been shown to be safe and to trigger an immune response.
A vaccine against the deadly virus has passed a key testing milestone, but it’s not a long-term solution to stop it.